Market Access Strategy
Market access, pricing and rembursement, for pharmaceuticals, biotechnology products, diagnostics and medical devices is becoming increasingly restricted with mandatory price cuts, restrictions placed on prescribing freedom, health technology assessments, budget processes, formularies and the professionalisation of procurement.
Bridgehead has a substantial track record in global markets covering pricing, reimbursement and market access strategy, parallel trade, economic modelling and compilation of dossiers for submission to national evaluation agencies.
Bridgehead draws on broad skills and experience, including company and payer perspectives, to advise clients at all stages of product development and commercialisation.
